Re: "Upper and lower system nasolacrimal duct stenosis secondary to paclitaxel"

Ophthalmic Plastic and Reconstructive Surgery

Volumn 25, Issue 5, 2009, Pages 418-419

  Savar, Aaron ^b   Esmaeli, Bita ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; PACLITAXEL;

ANGIOSARCOMA; BREAST CANCER; CANCER RADIOTHERAPY; EPIPHORA; EXTERNAL BEAM RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; KERATINIZATION; LACRIMAL DUCT; LACRIMAL DUCT OCCLUSION; LETTER; NOSE MUCOSA; PRIORITY JOURNAL; PSEUDOEPILEPTIC SEIZURE;

COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HEMANGIOSARCOMA; HUMANS; LACRIMAL DUCT OBSTRUCTION; NASOLACRIMAL DUCT; PACLITAXEL; TUBULIN MODULATORS;

EID: 70349755920     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e3181b398b6     Document Type: Letter

References (6)

1. McCartney E, Valluri S, Rushing D, Burgett R. Upper and lower system nasolacrimal duct stenosis secondary to paclitaxel. Ophthal Plast Reconstr Surg 2007;23:170-171 (Pubitemid 46596622)
2. Esmaeli B, Amin S, Valero V, et al. Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel. J Clin Oncol 2006;24:3619-3622 (Pubitemid 46630535)
3. Esmaeli B, Hidaji L, Adinin RB, et al. Blockage of the lacrimal drainage apparatus as a side effect of docetaxel. Cancer 2003;98:504-507
4. Call NB, Welham RA. Epiphora after irradiation of medial eyelid tumors. Am J Ophthalmol 1981;92:842-845
5. Diba R, Saadati H, Esmaeli B. Outcomes of dacryocystorhinostomy in patients with head and neck tumors. Head Neck 2005;27:72-75 (Pubitemid 40024092)
6. Esmaeli B, Burnstine MA, Ahmadi MA, Prieto VG. Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa. Ophthal Plast Reconstr Surg 2003;19:305-308 (Pubitemid 36899123)